Skin cancer in Australia provides comprehensive national information and statistics on skin cancer. It includes the latest available data and estimates to 2016, as well as trends over time. The report also describes risk factors, and presents a section on the limitations of non- melanoma skin cancer (NMSC) data in Australia, as well as future opportunities. Skin cancer accounts for the largest number of cancers diagnosed in Australia each year. In 2016, an estimated 13,280 new cases of melanoma will be diagnosed in Australia, and 1,770 people will die from this disease. The age-standardised incidence rate of melanoma has increased from 27 cases per 100,000 in 1982 to 49 per 100,000 in 2016. However, for people aged less than 40 the inciden...
This report presents the latest available data on the eye health workforce in Australia. It also pro...
This bulletin examines people’s use of aged care services in the 8 years before death, using the coh...
This report provides relative survival data up to nine years after diagnosis for women diagnosed in ...
SummaryBreastScreen Australia aims to reduce illness and death resulting from breast cancer through...
Summary: Cancer incidence in Australia is projected to rise due to an expected increase in both the ...
SummaryThe first annual report on the health indicators in the Indigenous Early Childhood Developme...
Summary The aim of this report is to provide information about children and young people aged 0-24 ...
This report presents the latest national statistics monitoring the National Cervical Screening Progr...
This is the first comprehensive national report on prostate cancer in Australia, presenting an over...
Presents statistics on the National Bowel Cancer Screening Program for Australians invited to take p...
On a snapshot day in 2012, almost 47,000 clients received pharmacotherapy treatment for their opio...
Presents the latest national statistics on BreastScreen, which aims to reduce illness and death resu...
This report on head and neck cancers in Australia presents the latest available information on incid...
Acute rheumatic fever (ARF) is rare in most developed countries, but rates among Aboriginal and Tor...
Presents a comparison of the mortality outcomes and cancer characteristics for two populations: thos...
This report presents the latest available data on the eye health workforce in Australia. It also pro...
This bulletin examines people’s use of aged care services in the 8 years before death, using the coh...
This report provides relative survival data up to nine years after diagnosis for women diagnosed in ...
SummaryBreastScreen Australia aims to reduce illness and death resulting from breast cancer through...
Summary: Cancer incidence in Australia is projected to rise due to an expected increase in both the ...
SummaryThe first annual report on the health indicators in the Indigenous Early Childhood Developme...
Summary The aim of this report is to provide information about children and young people aged 0-24 ...
This report presents the latest national statistics monitoring the National Cervical Screening Progr...
This is the first comprehensive national report on prostate cancer in Australia, presenting an over...
Presents statistics on the National Bowel Cancer Screening Program for Australians invited to take p...
On a snapshot day in 2012, almost 47,000 clients received pharmacotherapy treatment for their opio...
Presents the latest national statistics on BreastScreen, which aims to reduce illness and death resu...
This report on head and neck cancers in Australia presents the latest available information on incid...
Acute rheumatic fever (ARF) is rare in most developed countries, but rates among Aboriginal and Tor...
Presents a comparison of the mortality outcomes and cancer characteristics for two populations: thos...
This report presents the latest available data on the eye health workforce in Australia. It also pro...
This bulletin examines people’s use of aged care services in the 8 years before death, using the coh...
This report provides relative survival data up to nine years after diagnosis for women diagnosed in ...